22nd Century Group Inc. (XXII)
6.35
0.35 (5.83%)
At close: Jan 14, 2025, 3:59 PM
6.36
0.16%
Pre-market Jan 15, 2025, 06:18 AM EST
undefined% (undefined)
| Bid | 6.3 |
| Market Cap | 3.51M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -2419.2 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 6.45 |
| Volume | 14,071,087 |
| Avg. Volume (20D) | 495,953 |
| Open | 6.07 |
| Previous Close | 6.00 |
| Day's Range | 5.85 - 9.80 |
| 52-Week Range | 3.90 - 581.85 |
| Beta | undefined |
About XXII
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collabo...
Industry Tobacco
Sector Consumer Defensive
IPO Date Jan 26, 2011
Employees 64
Stock Exchange NASDAQ
Ticker Symbol XXII
Website https://www.xxiicentury.com
Analyst Forecast
According to 1 analyst ratings, the average rating for XXII stock is "Buy." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
1 day ago ·
Source
+22.7%
22nd Century Group shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago ·
Source
-33.17%
22nd Century shares are trading lower after the company announced a 1-for-135 reverse stock split.
